Nutraceuticals for Treatment of High Blood Pressure Values in Patients with Metabolic Syndrome
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Aim: To assess whether the association of a dietary supplement with a correct diet can decrease the incidence of metabolic syndrome. In particular, we studied the effect of a combination of Ortosiphon staminensis, which in rats exerts a diuretic effect, with policosanol, red yeast rice extract, berberine, folic acid and coenzyme Q10 on the determinants of metabolic syndrome diagnosis.
Methods: The analysed sample consisted of 21 males and 9 females, who were comparable in age, in order to obtain an adequate comparison between groups with similar demographic characteristics. Thirty patients with metabolic syndrome were divided into two study arms. Both groups received the usual diet recommended by the doctor according to their clinical conditions and placebo for 2 weeks before the beginning of the study, and then they were randomly assigned to two different drug regimens: placebo or the combination of nutraceuticals previously described, and were followed-up for 6 weeks.
Results: At baseline, there were no significant differences between the study and control groups for age, sex distribution, waist measurement, body mass index, systolic and diastolic blood pressure, familiarity for cardiovascular events, smoking habit, fasting glucose and lipid profile.At the end of the follow-up, only in the study group was there a significant reduction in systolic and diastolic blood pressure (−19.6±9.7 vs −3.6±8.1 mmHg and −13.6±5.5 vs −2.3±5.3 mmHg; all p < 0.0001) associated with amarked decrease in low-density lipoprotein cholesterol and triglyceride plasma levels. Consequently, 10 of 15 patients in this group no longer satisfied the criteria for metabolic syndrome, while in the control group the ratio was of 2 of 15.
Conclusions: The addition of Ortosiphon staminensis to the combination of policosanol, red yeast rice extract, berberine, folic acid and coenzyme Q10 provides an antihypertensive effect, which allows an effective control of blood pressure in patients with metabolic syndrome.
- Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 Oct 25; 112(17): 2735–52 CrossRef
- Mancia G, De Backer G, Dominiczak A, et al. 2007Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25(6): 1105–87 CrossRef
- Azadbakht L, Mirmiran P, Esmaillzadeh A, et al. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005 Dec; 28(12): 2823–31 CrossRef
- Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005 Nov; 28(11): 2745–9 CrossRef
- Mattar M, Obeid O. Fish oil and the management of hypertriglyceridemia. Nutr Health 2009; 20(1): 41–9 CrossRef
- Cicero AFG, Rovati L, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. Arzneimittelforschung 2007; 57(1): 26–30
- Senin P, Setnikar I, Rovati AL. Formulation for oral administration having a health-promoting effect on the cardiovascular system [European patent]. EP 1 827 136 B1 04.06. 2008
- Trimarco B, Benvenuti C. Controlled clinical study on a new dietary supplement active on cholesterol and triglycerides in CV risk and metabolic syndrome control [abstract no. 950109]. XV International Symposium on Atherosclerosis; 2009 Jun 14-18; Boston (MA)
- Adam Y, Somchit MN, Sulaiman MR, et al. Diuretic properties of Orthosiphon stamineus Benth. J Ethnopharmacol 2009 Jul 6; 124(1): 154–8 CrossRef
- Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 May 16; 285 (19): 2486–97
- Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117–24 CrossRef
- Dickinson HO, Nicolson DJ, Campbell F, et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006; (3): CD004640
- Stamler J, Brown IJ, Daviglus ML, et al. Glutamic acid, the main dietary amino acid, and blood pressure. The INTERMAP study (International Collaborative Study of Macronutrients, Micronutrients and Blood Pressure). Circulation 2009; 1203: 221–8 CrossRef
- Nutraceuticals for Treatment of High Blood Pressure Values in Patients with Metabolic Syndrome
High Blood Pressure & Cardiovascular Prevention
Volume 16, Issue 4 , pp 177-182
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- antihypertensive therapy
- Industry Sectors
- Author Affiliations
- 1. Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University, Via Sergio Pansini 5, bld 2–, 80131, Naples, Italy
- 2. Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy